Featured Slider

EAN President, Paul Boon, on the forthcoming Brain Health Summit, EAN advocacy activities, the recent national societies forum, and more.

Our April paper of the month investigates the association between focal epilepsy and risk of incident dementia compared with patients with stroke or migraine and with healthy controls.

EAN Education Committee Chair, Irena Rektorová, gives an update on new projects, upcoming deadlines, and some exciting additions to existing educational programmes.

Our paper of the month presents the results of a prospective, double-blind, randomised, sham-controlled trial involving 16 centres and investigating the safety and efficacy of unilateral FUSA of the globus pallidus internus in patients with medication-refractory idiopathic PD.

President of the Turkish Neurological Society, shares a statement on the tragic aftermath of the earthquake in Türkiye and Syria and honours the memory of the neurologists lost.

EAN President, Paul Boon, provides an update on some upcoming major EAN events (including EAN 2023) and freshly launched EAN projects.

Our February Paper of the Month is a narrative review focusing on epidemiology, pathophysiology and treatment of secondary headache following SARS-COV-2 infection and vaccination, and on the impact of COVID-19 pandemic on primary headache disorders.

Under the auspices of the Czech Presidency of the Council of the European Union and with support from MEP Ondřej Knotek, The European Academy of Neurology (EAN) gathered a range of stakeholders at the European Parliament in Brussels on Thursday, December 8 to give them a glimpse of EAN’s forthcoming research agenda.

Our paper of the month reports the results of the ENCHANTED 2/MT trial, performed in 44 Chinese hospitals to compare more intensive with less intensive blood pressure management after successful endovascular thrombectomy.

Our authors of the month compared the occurrence of stroke, utilisation of recanalisation procedures, and demographic parameters during the pandemic period with data from the preceding year.

Abstract submission for our next annual congress is now open! EAN Programme Committee Chair, Prof. Ulf Kallweit shares the details on this and other latest news about EAN 2023.

Our authors of the month report the results of a multicentre phase-3 clinical trial exploring efficacy and safety of Lecanemab in patients with early AD over a follow-up period of eighteen months.

Our authors of the month conducted a retrospective study of the potential association between COVID-19 and seizures or epilepsy in the six months after infection, using an electronic health records network of 81 million people.

EAN Scientific Committee Chair, Prof. Thomas Berger, provides a general update, including guideline prioritisation news, ongoing research projects and the forthcoming 2nd EAN Science School.

Our research paper of the month presents the results of the Endovascular Treatment for Acute Basilar-Artery Occlusion (ATTENTION) trial; a multicentre, prospective, randomised and open-label trial, conducted in 36 Chinese centres.